CN Stock MarketDetailed Quotes

600557 Jiangsu Kanion Pharmaceutical

Watchlist

14.39
+0.32+2.27%

Trading Mar 4 10:54 CST

8.19BMarket Cap15.05P/E (TTM)

Jiangsu Kanion Pharmaceutical Stock Forum

Moomoo AI

Feb 1, 2024 16:51

Investors attribute Jiangsu Kanion Pharmaceutical Co.,Ltd.'s low P/E ratio to limited future growth expectations. The poor earnings outlook contributes to its low P/E, with shareholders not anticipating pleasant surprises in future earnings, making a significant share price rise unlikely.